A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 33/36 (2006.01) A61K 9/00 (2006.01) A61K 9/48 (2006.01) A61K 47/00 (2006.01) A61K 47/04 (2006.01) A61K 47/44 (2006.01) A61K 47/48 (2006.01) A61P 9/10 (2006.01) A61P 19/00 (2006.01) A61P 35/00 (2006.01) A61K 47/06 (2006.01) A61K 47/10 (2006.01) A61K 47/26 (2006.01)
Patent
CA 2466303
The invention relates to a method of selectively targeting an active agent (or agent capable of becoming an active agent) to apoptotic cells in a vertebrate, comprising administering to said vertebrate a system comprising an arsenoxide (or arsenoxide equivalent) compound and said agent, wherein said system selectively targets apoptotic cells.
L'invention se rapporte à un procédé de ciblage sélectif d'un principe actif (ou agent capable de se transformer en principe actif) vers des cellules apoptiques chez un vertébré, qui consiste à administrer à un vertébré un système comprenant un procédé arsenoxide (ou équivalent arsenoxide) et ledit agent, ledit système ciblant de manière sélective les cellules apoptiques.
Newsouth Innovations Pty Limited
Smart & Biggar
Unisearch Limited
LandOfFree
Selective targeting of apoptotic cells does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Selective targeting of apoptotic cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Selective targeting of apoptotic cells will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1583365